Osteonecrosis of the jaw in patients with cancer who received zoledronic acid and bevacizumab

Toxicity and response criteria of the Eastern Cooperative Oncology Group

Martin M. Oken, Richard H. Creech, Douglass C. Tormey et al. · American Journal of Clinical Oncology · 1982 · 11.4K citations

Health Sciences, Medicine, Cancer Management +14

Bisphosphonate-Induced Exposed Bone (Osteonecrosis/Osteopetrosis) of the Jaws: Risk Factors, Recognition, Prevention, and Treatment

Robert E. Marx, Yoh Sawatari, Michel Fortin et al. · Journal of Oral and Maxillofacial Surgery · 2005 · 1.6K citations

Bone Disease, Bone Health, Osteoarthritis +4

Osteonecrosis of the Jaw in Cancer After Treatment With Bisphosphonates: Incidence and Risk Factors

Aristotle Bamias, Efstathios Kastritis, Christina Bamia et al. · Journal of Clinical Oncology · 2005 · 1.1K citations · Full text

Novel Antiangiogenic Effects of the Bisphosphonate Compound Zoledronic Acid

Jeanette M. Wood, Karine Bonjean, Stephan Ruetz et al. · Journal of Pharmacology and Experimental Therapeutics · 2002 · 844 citations

Frequency and Risk Factors Associated With Osteonecrosis of the Jaw in Cancer Patients Treated With Intravenous Bisphosphonates

Ana O. Hoff, Béla B. Toth, Kadri Altundağ et al. · Journal of Bone and Mineral Research · 2008 · 632 citations · Full text